{"entity":{"id":"nct07831863","kind":"trial","name":"A Study of 7MW3711 Compared With Docetaxel in Advanced Squamous NSCLC After Prior Chemoimmunotherapy","aka":[],"tldr":"A phase 3 trial of docetaxel in lung cancer, run by Mabwell (Shanghai) Bioscience Co., Ltd., not yet recruiting.","summary":"A Study of 7MW3711 Compared With Docetaxel in Advanced Squamous NSCLC After Prior Chemoimmunotherapy is a phase 3, randomised interventional study registered as NCT07831863 by Mabwell (Shanghai) Bioscience Co., Ltd., with a registry enrolment figure of 600 participants, started 2026-10 and due to reach its primary completion in 2029-03. Interventions recorded: 7MW3711; Docetaxel. Conditions listed: Lung Squamous Cell Carcinoma. Primary outcome: Overall Survival. Lung eligibility wording from the registry: \"* Histologically or cytologically confirmed unresectable locally advanced or metastatic squamous non-small cell lung cancer (NSCLC)\". Sites: China. No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT07831863","url":"https://clinicaltrials.gov/study/NCT07831863"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["lung-squamous-cell-carcinoma"],"sections":[],"technologies":["cytotoxic-chemotherapy"],"targets":[],"drugs":["docetaxel"],"companies":["mabwell-shanghai-bioscience"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07831863","phase":"3","setting":"A Phase III, Open-label, Randomized-controlled, Multi-center Study of 7MW3711 Compared With Docetaxel in Patients With Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer Previously Treated With Platinum-based Chemotherapy and Immunotherapy","sponsor":"Mabwell (Shanghai) Bioscience Co., Ltd.","participation":[{"nct":"NCT07831863","source":"https://clinicaltrials.gov/study/NCT07831863","fetchedAt":"2026-10-07T16:56:52.065Z","studySha256":"9bc91922b4cafdb2c0599ec50902c1ba27dab66cb0908e3224a149d6fa0c6cbe","overallStatus":"NOT_YET_RECRUITING","lastUpdatePosted":"2026-09-21","leadSponsor":"Mabwell (Shanghai) Bioscience Co., Ltd.","collaboratorCount":0,"minimumAge":"18 Years","maximumAge":"85 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":600,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":0,"countries":["China"]}],"started":"2026-10","startedType":"estimated","enrolled":600,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07831863/","neighbours":{"cancer":[{"id":"lung-squamous-cell-carcinoma","kind":"cancer","name":"Squamous cell carcinoma of the lung","route":"/cancers/lung-squamous-cell-carcinoma/"}],"technology":[{"id":"cytotoxic-chemotherapy","kind":"technology","name":"Cytotoxic chemotherapy","route":"/technologies/cytotoxic-chemotherapy/"}],"drug":[{"id":"docetaxel","kind":"drug","name":"Docetaxel","route":"/drugs/docetaxel/"}],"company":[{"id":"mabwell-shanghai-bioscience","kind":"company","name":"Mabwell (Shanghai) Bioscience","route":"/companies/mabwell-shanghai-bioscience/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}